Annual Operating Profit
-$129.50 M
-$69.56 M-116.03%
31 December 2023
Summary:
Poseida Therapeutics annual operaing income is currently -$129.50 million, with the most recent change of -$69.56 million (-116.03%) on 31 December 2023. During the last 3 years, it has fallen by -$2.96 million (-2.34%). PSTX annual operating profit is now -499.75% below its all-time high of -$21.59 million, reached on 31 December 2017.PSTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$19.74 M
+$51.50 M+162.17%
30 September 2024
Summary:
Poseida Therapeutics quarterly operating income is currently $19.74 million, with the most recent change of +$51.50 million (+162.17%) on 30 September 2024. Over the past year, it has increased by +$55.96 million (+154.50%). PSTX quarterly operating profit is now -72.50% below its all-time high of $71.78 million, reached on 30 September 2022.PSTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$62.50 M
+$55.96 M+47.24%
30 September 2024
Summary:
Poseida Therapeutics TTM operating income is currently -$62.50 million, with the most recent change of +$55.96 million (+47.24%) on 30 September 2024. Over the past year, it has increased by +$74.31 million (+54.32%). PSTX TTM operating profit is now -316.33% below its all-time high of -$15.01 million, reached on 31 March 2019.PSTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -116.0% | +154.5% | +54.3% |
| 3 y3 years | -2.3% | +147.5% | +60.8% |
| 5 y5 years | -219.3% | +200.2% | -12.3% |
PSTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -116.0% | +8.4% | -72.5% | +134.7% | -116.9% | +61.2% |
| 5 y | 5 years | -219.3% | +8.4% | -72.5% | +134.7% | -116.9% | +61.2% |
| alltime | all time | -499.8% | +8.4% | -72.5% | +134.7% | -316.3% | +61.2% |
Poseida Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $19.74 M(-162.2%) | -$62.50 M(-47.2%) |
| June 2024 | - | -$31.76 M(+29.2%) | -$118.46 M(+3.4%) |
| Mar 2024 | - | -$24.58 M(-5.1%) | -$114.56 M(-11.5%) |
| Dec 2023 | -$129.50 M(+116.0%) | -$25.91 M(-28.5%) | -$129.50 M(-5.3%) |
| Sept 2023 | - | -$36.22 M(+30.0%) | -$136.81 M(+374.9%) |
| June 2023 | - | -$27.86 M(-29.5%) | -$28.81 M(-32.2%) |
| Mar 2023 | - | -$39.52 M(+18.9%) | -$42.50 M(-29.1%) |
| Dec 2022 | -$59.95 M(-57.6%) | -$33.22 M(-146.3%) | -$59.95 M(+35.6%) |
| Sept 2022 | - | $71.78 M(-272.8%) | -$44.20 M(-71.9%) |
| June 2022 | - | -$41.55 M(-27.1%) | -$157.57 M(-2.1%) |
| Mar 2022 | - | -$56.96 M(+225.9%) | -$160.91 M(+13.8%) |
| Dec 2021 | -$141.41 M | -$17.48 M(-58.0%) | -$141.41 M(-11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$41.59 M(-7.3%) | -$159.29 M(+5.4%) |
| June 2021 | - | -$44.88 M(+19.8%) | -$151.18 M(+11.4%) |
| Mar 2021 | - | -$37.46 M(+6.0%) | -$135.74 M(+7.3%) |
| Dec 2020 | -$126.55 M(+60.5%) | -$35.36 M(+5.6%) | -$126.55 M(+10.6%) |
| Sept 2020 | - | -$33.47 M(+13.7%) | -$114.40 M(+13.7%) |
| June 2020 | - | -$29.45 M(+4.2%) | -$100.63 M(+9.3%) |
| Mar 2020 | - | -$28.27 M(+21.8%) | -$92.11 M(+16.8%) |
| Dec 2019 | -$78.85 M(+94.4%) | -$23.21 M(+17.8%) | -$78.85 M(+41.7%) |
| Sept 2019 | - | -$19.70 M(-5.8%) | -$55.64 M(+54.8%) |
| June 2019 | - | -$20.92 M(+39.4%) | -$35.94 M(+139.4%) |
| Mar 2019 | - | -$15.01 M | -$15.01 M |
| Dec 2018 | -$40.56 M(+87.8%) | - | - |
| Dec 2017 | -$21.59 M | - | - |
FAQ
- What is Poseida Therapeutics annual operaing income?
- What is the all time high annual operating profit for Poseida Therapeutics?
- What is Poseida Therapeutics annual operating profit year-on-year change?
- What is Poseida Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly operating profit year-on-year change?
- What is Poseida Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Poseida Therapeutics?
- What is Poseida Therapeutics TTM operating profit year-on-year change?
What is Poseida Therapeutics annual operaing income?
The current annual operating profit of PSTX is -$129.50 M
What is the all time high annual operating profit for Poseida Therapeutics?
Poseida Therapeutics all-time high annual operaing income is -$21.59 M
What is Poseida Therapeutics annual operating profit year-on-year change?
Over the past year, PSTX annual operaing income has changed by -$69.56 M (-116.03%)
What is Poseida Therapeutics quarterly operating income?
The current quarterly operating profit of PSTX is $19.74 M
What is the all time high quarterly operating profit for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly operating income is $71.78 M
What is Poseida Therapeutics quarterly operating profit year-on-year change?
Over the past year, PSTX quarterly operating income has changed by +$55.96 M (+154.50%)
What is Poseida Therapeutics TTM operating income?
The current TTM operating profit of PSTX is -$62.50 M
What is the all time high TTM operating profit for Poseida Therapeutics?
Poseida Therapeutics all-time high TTM operating income is -$15.01 M
What is Poseida Therapeutics TTM operating profit year-on-year change?
Over the past year, PSTX TTM operating income has changed by +$74.31 M (+54.32%)